Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapy

BACKGROUND: The Birch Allergoid, Tyrosine Adsorbate, Monophosphoryl Lipid A (POLLINEX (®) Quattro Plus 1.0 ml Birch 100%) is an effective, well‐tolerated short course subcutaneous immunotherapy. We performed 2 phase II studies to determine its optimal cumulative dose. METHODS: The studies were condu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Allergy
Main Authors: Worm, M., Higenbottam, T., Pfaar, O., Mösges, R., Aberer, W., Gunawardena, K., Wessiepe, D., Lee, D., Kramer, M. F., Skinner, M., Lees, B., Zielen, S.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2018
Teme:
ORIGINAL ARTICLES
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6175210/
https://ncbi.nlm.nih.gov/pubmed/29779247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/all.13478
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki